Cookson Peirce & CO Inc Catalent, Inc. Transaction History

Cookson Peirce & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$100.34 - $115.69 $247,137 - $284,944	-2,463 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$101.51 - $125.27 $250,019 - $308,540	2,463 New	2,463 $259,000
Q3 2019 Nov 05, 2019	SELL	$47.45 - $58.05 $336,657 - $411,864	-7,095 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$39.26 - $54.21 $278,549 - $384,619	7,095 New	7,095 $0

463

148M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.